FLAG-003 for GBM and DIPG
AG488 as a therapy against gliomas
Ziegler et al. Oncotarget, 8(42):71833-71844, May 2017
The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as
multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents
Zhang et al. Bioorg Med Chem, 22(14):3753-72, July 2014
Diffuse intrinsic pontine glioma: current insights and future directions.
Srikanthan et al. Chin Neurosurg J, 7(1):6, January 2021
FLAG-094 for Mesothelioma
Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter.
Cherian et al. Cancer Chemother Pharmacol, 71(4):999-1011, April 2013
Structural and Enzymatic Analysis of Tumor-Targeted Antifolates That Inhibit Glycinamide Ribonucleotide Formyltransferase.
Deis et al. Biochemistry, 55(32):4574-82, August 2016
FLAG-094 for Ovarian Cancer
Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-d]pyrimidine Antifolates.
Hou et al. Mol Cancer Ther, 16(5):819-830, May 2017
Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment.
Wallace-Povirk et al. Sci Rep, 2(1):11346, July 2022
Pancreatic Cancer
Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism.
Dekhne et al. Mol Pharmacol, 97(1):9-22, January 2020
SHMT2
A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight.
Cuthbertson et al. ACS Pharmacol Transl Sci, 4(2):624-646, March 2021
Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer.
Dekhne et al. Mol Cancer Ther, 19(11):2245-2255, November 2020
Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma
Ducker et al. Proc Natl Acad Sci, 114(43):11404-11409, October 2017
Select Publications
The following is a list of select publications relating to investigational drug discovery platforms and investigational product candidates being evaluated by FLAG Therapeutics.